200 related articles for article (PubMed ID: 29446568)
1. Making a (cautious) case for expanding reproductive genetic carrier screens: Australian researchers report success, and caveats, with a simultaneous panel of cystic fibrosis, fragile X syndrome, and spinal muscular atrophy.
Am J Med Genet A; 2018 Mar; 176(3):510-512. PubMed ID: 29446568
[No Abstract] [Full Text] [Related]
2. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.
Archibald AD; Smith MJ; Burgess T; Scarff KL; Elliott J; Hunt CE; McDonald Z; Barns-Jenkins C; Holt C; Sandoval K; Siva Kumar V; Ward L; Allen EC; Collis SV; Cowie S; Francis D; Delatycki MB; Yiu EM; Massie RJ; Pertile MD; du Sart D; Bruno D; Amor DJ
Genet Med; 2018 Apr; 20(5):513-523. PubMed ID: 29261177
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic status and uptake of reproductive carrier screening in Australia.
Robson SJ; Caramins M; Saad M; Suthers G
Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):976-979. PubMed ID: 32748403
[TBL] [Abstract][Full Text] [Related]
4. "I'm Healthy, It's Not Going To Be Me": Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia.
Beard CA; Amor DJ; Di Pietro L; Archibald AD
Am J Med Genet A; 2016 Aug; 170(8):2052-9. PubMed ID: 27150953
[TBL] [Abstract][Full Text] [Related]
5. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2023; 23(4):1-398. PubMed ID: 37637488
[TBL] [Abstract][Full Text] [Related]
6. Population screening for reproductive risk for single gene disorders in Australia: now and the future.
Delatycki MB
Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742
[TBL] [Abstract][Full Text] [Related]
7. Expanded Carrier Screening.
Gregg AR
Obstet Gynecol Clin North Am; 2018 Mar; 45(1):103-112. PubMed ID: 29428278
[TBL] [Abstract][Full Text] [Related]
8. Expanded carrier screening: A review of early implementation and literature.
Lazarin GA; Haque IS
Semin Perinatol; 2016 Feb; 40(1):29-34. PubMed ID: 26718446
[TBL] [Abstract][Full Text] [Related]
9. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome and spinal muscular atrophy: patterns of community and healthcare provider participation in a Victorian screening program.
Leibowitz R; Lewis S; Emery J; Massie J; Smith M; Delatycki M; Archibald A
Aust J Prim Health; 2022 Dec; 28(6):580-587. PubMed ID: 36192111
[TBL] [Abstract][Full Text] [Related]
10. Screening for single gene genetic disease.
Musci TJ
Gynecol Obstet Invest; 2005; 60(1):19-26. PubMed ID: 15731563
[TBL] [Abstract][Full Text] [Related]
11. Expanded carrier screening and the law of unintended consequences: from cystic fibrosis to fragile X.
Grody WW
Genet Med; 2011 Dec; 13(12):996-7. PubMed ID: 22134443
[No Abstract] [Full Text] [Related]
12. Population-based genetic carrier screening for cystic fibrosis in Victoria.
Archibald AD; Massie J; Smith MJ; Dalton DG; du Sart D; Amor DJ
Med J Aust; 2014 Mar; 200(4):205-6. PubMed ID: 24580517
[No Abstract] [Full Text] [Related]
13. Expanded carrier screening in gamete donors of Venezuela.
Urbina MT; Benjamin I; Medina R; Jiménez J; Trías L; Lerner J
JBRA Assist Reprod; 2017 Dec; 21(4):356-360. PubMed ID: 29099150
[TBL] [Abstract][Full Text] [Related]
14. Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.
Zhang L; Bao Y; Riaz M; Tiller J; Liew D; Zhuang X; Amor DJ; Huq A; Petelin L; Nelson M; James PA; Winship I; McNeil JJ; Lacaze P
Genet Med; 2019 Sep; 21(9):1958-1968. PubMed ID: 30773532
[TBL] [Abstract][Full Text] [Related]
15. Carrier testing for spinal muscular atrophy.
Gitlin JM; Fischbeck K; Crawford TO; Cwik V; Fleischman A; Gonye K; Heine D; Hobby K; Kaufmann P; Keiles S; MacKenzie A; Musci T; Prior T; Lloyd-Puryear M; Sugarman EA; Terry SF; Urv T; Wang C; Watson M; Yaron Y; Frosst P; Howell RR
Genet Med; 2010 Oct; 12(10):621-2. PubMed ID: 20808230
[TBL] [Abstract][Full Text] [Related]
16. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens.
Sugarman EA; Nagan N; Zhu H; Akmaev VR; Zhou Z; Rohlfs EM; Flynn K; Hendrickson BC; Scholl T; Sirko-Osadsa DA; Allitto BA
Eur J Hum Genet; 2012 Jan; 20(1):27-32. PubMed ID: 21811307
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis, genetics, and DNA technology.
Nugent CE
Curr Opin Obstet Gynecol; 1991 Apr; 3(2):235-41. PubMed ID: 1912355
[TBL] [Abstract][Full Text] [Related]
18. Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy.
Mouawia H; Saker A; Jais JP; Benachi A; Bussières L; Lacour B; Bonnefont JP; Frydman R; Simpson JL; Paterlini-Brechot P
Reprod Biomed Online; 2012 Nov; 25(5):508-20. PubMed ID: 23000084
[TBL] [Abstract][Full Text] [Related]
19. Prenatal genetic testing.
Dolan SM
Pediatr Ann; 2009 Aug; 38(8):426-30. PubMed ID: 19711880
[No Abstract] [Full Text] [Related]
20. Genetic counseling and carrier screening in candidates for gamete donation at a Portuguese center.
Soares CA; Tkachenko N; Vale-Fernandes E; Barreiro M; Abreu M; Reis CF; Soares G; Fortuna AM; Soares AR
JBRA Assist Reprod; 2023 Jun; 27(2):180-184. PubMed ID: 35916466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
